Screener
Charles River Laboratories CRL Restructuring Reserve Accrual Adjustment1
Restructuring Reserve Accrual Adjustment1 at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RestructuringReserveAccrualAdjustment1.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Six Months Ended June 27, 2026 | Severance and Transition Costs | Asset Impairments | Other Costs | Total |
|---|---|---|---|---|
| Beginning balance | $23,005 | — | — | $23,005 |
| Expense | 8,471 | 26,086 | 20,080 | 54,637 |
| Payments / utilization | (15,794) | — | (16,408) | (32,202) |
| Other non-cash adjustments | — | (26,086) | (3,672) | (29,758) |
| Foreign currency adjustments | (114) | — | — | (114) |
| Ending Balance | $15,568 | — | — | $15,568 |
| Six Months Ended June 28, 2025 | ||||
| Beginning balance | $24,469 | — | $875 | $25,344 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's restructuring reserve accrual adjustment1?
- Charles River Laboratories (CRL) reported restructuring reserve accrual adjustment1 of -$13.47M in Q2 2026.
- How has Charles River Laboratories's restructuring reserve accrual adjustment1 changed year-over-year?
- Charles River Laboratories's restructuring reserve accrual adjustment1 increased by 39.2% year-over-year, from -$22.16M to -$13.47M.
- What does restructuring reserve accrual adjustment1 mean?
- Restructuring Reserve Accrual Adjustment1
Ask your AI about Charles River Laboratories's restructuring reserve accrual adjustment1.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude